Agents and Actions

, Volume 6, Issue 4, pp 510–515 | Cite as

Correlation of pulmonary structure with pharmacokinetic function

  • J. W. Ryan
  • Una S. Ryan
Article

Keywords

Pulmonary Structure Pharmacokinetic Function 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    E.H. Starling andE.B. Verney,The Secretion of Urine as Studied on the Isolated Kidney, Proc. R. Soc., Lond. [B]97, 321–363 (1925).Google Scholar
  2. [2]
    B. Eiseman, L. Bryant andT. Waltuch,Metabolism of Vasomotor Agents by the Isolated Perfused Lung, J. Thoracic Cardiovasc. Surg.48, 798–806 (1964).Google Scholar
  3. [3]
    R.L. Hodge, R.D. Lowe andJ.R. Vane,Increased Angiotensin Formation in Response to Carotid Occlusion in the Dog, Nature211, 491–493 (1966).PubMedGoogle Scholar
  4. [4]
    S.H. Ferreira andJ.R. Vane,Half-Lives of Peptides and Amines in the Circulation, Nature215, 1237–1240 (1967).PubMedGoogle Scholar
  5. [5]
    S.H. Ferreira andJ.R. Vane,Prostaglandins: Their Disappearance from and Release into the Circulation, Nature216, 868–873 (1967).PubMedGoogle Scholar
  6. [6]
    R.L. Hodge, K.K.F. Ng andJ.R. Vane,Disappearance of Angiotensin from the Circulation of the Dog, Nature215, 138–141 (1967).PubMedGoogle Scholar
  7. [7]
    K.K.F. Ng andJ.R. Vane,Conversion of Angiotensin I to Angiotensin II, Nature216, 762–766 (1967).PubMedGoogle Scholar
  8. [8]
    K.K.F. Ng andJ.R. Vane,Fate of Angiotensin I in the Circulation, Nature218, 144–150 (1968).PubMedGoogle Scholar
  9. [9]
    J.R. Vane,The Release and Fate of Vaso-Active Hormones in the Circulation, Br. J. Pharmac.35, 209–242 (1969).Google Scholar
  10. [10]
    J. Hughes, C.N. Gillis andF.E. Bloom,The Uptake and Disposition of d-Norepinephrine in Perfused Rat Lung, J. Pharmac. exp. Ther.169, 237–248 (1969).Google Scholar
  11. [11]
    J.M. Strum andA.F. Junod,Autoradiographic Demonstration of 5-Hydroxy-Tryptamine-3 H Uptake by Pulmonary Endothelial Cells, J. Cell Biol.54, 456–467 (1972).CrossRefPubMedGoogle Scholar
  12. [12]
    T.E. Nicholas, J.M. Strum, L.S. Angelo andA.F. Junod,Site and Mechanism of Uptake of 3 H-L-Norepinephrine by Isolated Perfused Rat Lungs, Circ. Res.35, 670–680 (1974).PubMedGoogle Scholar
  13. [13]
    J.W. Ryan andU. Smith,Metabolism of Adenosine-5′-Monophosphate during Circulation through the Lungs, Trans Ass. Am. Phys.84, 297–306 (1971).Google Scholar
  14. [14]
    J.W. Ryan, R.S. Niemeyer andD.W. Goodwin,Metabolic Fates of Bradykinin, Angiotensin I, Adenine Nucleotides and Prostaglandins E 1 and F 1 in the Pulmonary Circulation, in:N. Back andF. Sicuteri, Adv. exp. Med. Biol., vol. 21 (Plenum Press, New York 1972), p. 259–266.Google Scholar
  15. [15]
    J.W. Ryan, R.S. Niemeyer andU.S. Ryan,Metabolism of Prostaglandin F in the Pulmonary Circulation, Prostaglandins10, 101–108 (1975).CrossRefPubMedGoogle Scholar
  16. [16]
    J. Hartiala,Testosterone Metabolism in Rabbit Lung in vitro, Steroids Lipids Res.5, 91–95 (1974).PubMedGoogle Scholar
  17. [17]
    G. Giannopoulos,Uptake and Metabolism of Cortisone and Cortisol by the Fetal Rabbit Lung, Steroids23, 845–853 (1974).CrossRefPubMedGoogle Scholar
  18. [18]
    N.S. Wang, R.V. Kotas, M.E. Avery andW.M. Thurlbeck,Accelerated Appearance of Osmiophilic Bodies in Fetal Lungs Following Steroid Injection, J. appl. Physiol.30, 362–365 (1971).PubMedGoogle Scholar
  19. [19]
    T.E. Nicholas andP.A. Kim,The Metabolism of 3 H-Cortisone and 3 H-Cortisol by the Isolated Perfused Rat and Guinea-Pig Lungs, Steroids25, 387–402 (1975).CrossRefPubMedGoogle Scholar
  20. [20]
    J.W. Ryan, J. Roblero andJ.M. Stewart,Inactivation of Bradykinin in the Pulmonary Circulation, Biochem. J.110, 795–797 (1968).PubMedGoogle Scholar
  21. [21]
    J.W. Ryan, J. Roblero andJ.M. Stewart,Inactivation of Bradykinin in Rat Lung, Pharmac. Res. Commun.1, 192 (1969).Google Scholar
  22. [22]
    J.W. Ryan, J. Roblero andJ.M. Stewart,Inactivation of Bradykinin in Rat Lung, in:N. Back, F. Sicuteri andM. Rocha eSilva, Adv. exp. Med. Biol. vol. 8 (Plenum Press, New York 1970), p. 263–271.Google Scholar
  23. [23]
    S.H. Ferreira,A Bradykinin-Potentiating Factor (BPF) Present in the Venom of Bothrops jararaca, Br. J. Pharmac. Chemother.24, 163–169 (1965).Google Scholar
  24. [24]
    S.H. Ferreira, D.C. Bartelt andL.J. Greene,Isolation of Bradykinin-Potentiating Peptides from Bothrops jararaca Venom, Biochemistry9, 2583–2593 (1970).CrossRefPubMedGoogle Scholar
  25. [25]
    Y.S. Bakhle,Converting Enzyme in vitro Its Measurements and Properties, in:I.H. Page andF.M. Bumpus, Handb. exp. Pharmac., vol. 37 (Springer-Verlag, Berlin 1974), p. 41–80.Google Scholar
  26. [26]
    F.E. Dorer, J.R. Kahn, K.E. Lentz, M. Levine andL.T. Skeggs,Purification and Properties of Angiotensin-Converting Enzyme from Hog Lung, Circ. Res.31, 356–366 (1972).PubMedGoogle Scholar
  27. [27]
    F.E. Dorer, J.R. Kahn, K.E. Lentz, M. Levine andL.T. Skeggs,Hydrolysis of Bradykinin by Angiotensin-Converting Enzyme, Circ. Res.34, 824–827 (1974).PubMedGoogle Scholar
  28. [28]
    J.A. Goffinet andP.J. Mulrow,Estimation of Angiotensin Clearance by an in vivo Assay, Clin. Res.11, 408 (1963).Google Scholar
  29. [29]
    J. Roblero, J.W. Ryan andJ.M. Stewart,Assay of Kinins by Their Effects on Blood Pressure, Res. Commun. Chem. Path. Pharmac.6, 207–212 (1973).Google Scholar
  30. [30]
    F.E. Dorer, J.W. Ryan andJ.M. Stewart,Hydrolysis of Bradykinin and Its Higher Homologues by Angiotensin-Converting Enzyme, Biochem. J.141, 915–917 (1974).PubMedGoogle Scholar
  31. [31]
    J.W. Ryan, J.M. Stewart, W.P. Leary andJ.G. Ledingham,Metabolism of Angiotensin I in the Pulmonary Circulation, Biochem. J.120, 221–223 (1970).PubMedGoogle Scholar
  32. [32]
    J.W. Ryan, R.S. Niemeyer, D.W. Goodwin, U. Smith andJ.M. Stewart,Metabolism of (8-l-[14 C]phenylalanine)-Angiotensin I in the Pulmonary Circulation, Biochem. J.125, 921–923 (1971).PubMedGoogle Scholar
  33. [33]
    J.W. Ryan, U. Smith andR.S. Niemeyer,Angiotensin I: Metabolism by Plasma Membrane of Lung, Science176, 64–66 (1972).PubMedGoogle Scholar
  34. [34]
    R.K. Türker, M. Yamamoto, F.M. Bumpus andP.A. Khairallah,Lung Perfusion with Angiotensin I and II. Evidence of Release of Myotropic and Inhibitory Substances, Circ. Res.28, 559–567 (1971).Google Scholar
  35. [35]
    J.W. Ryan andU. Smith,A Rapid, Simple Method for Isolating Pinocytotic Vesicles and Plasma Membrane of Lung, Biochim. biophys. Acta249, 177–180 (1971).PubMedGoogle Scholar
  36. [36]
    U. Smith andJ.W. Ryan,Pinocytotic Vesicles of the Pulmonary Endothelial Cell, Chest59, 12S-15S (1971).PubMedGoogle Scholar
  37. [37]
    U. Smith andJ.W. Ryan,An Electron Microscopic Study of the Vascular Endothelium as a Site for Bradykinin and ATP Inactivation in Rat Lung, in:N. Back, F. Sicuteri andM. Rocha eSilva, Adv. Exp. Med. Biol., vol. 8 (Plenum Press, New York 1970), p. 249–261.Google Scholar
  38. [38]
    J.W. Ryan andU. Smith,The Metabolism of Angiotensin I by Endothelial Cells, in: H. Peters,Protides of the Biological Fluids, vol. 20 (Pergamon Press, Oxford 1973), p. 379–384.Google Scholar
  39. [39]
    U. Smith andJ.W. Ryan,Pulmonary Endothelial Cells and Metabolism of Adenine Nucleotides, Kinins and Angiotensin I, in:N. Back andF. Sicuteri, Adv. exp. Med. Biol., vol. 21 (Plenum Press, New York 1972), p. 267–276.Google Scholar
  40. [40]
    A.T. Chiu, J.W. Ryan, U.S. Ryan andF.E. Dorer,A Sensitive Radiochemical Assay for Angiotensin-Converting Enzyme (Kininase II), Biochem. J.149, 297–300 (1975).PubMedGoogle Scholar
  41. [41]
    M. Weigele, S. de Bernardo, W. Leimgruber, R. Cleeland andE. Grumberg,Fluorescent Labeling of Proteins. A New Methodology, Biochem. biophys. Res. Commun.54, 899–905 (1973).CrossRefPubMedGoogle Scholar
  42. [42]
    J.W. Ryan, U.S. Ryan, D.R. Schultz, C. Whitaker, A. Chung andF.E. Dorer,Subcellular Localization of Pulmonary Angiotensin-Converting Enzyme (Kininase II), Biochem. J.146, 497–499 (1975).PubMedGoogle Scholar
  43. [43]
    J.W. Ryan andU.S. Ryan,Metabolic Activities of Plasma Membrane and Caveolae of Pulmonary Endothelial Cells, in:R. de Haller, Proc. 5th Inter. Davos Symp. onAspects of Lung Metabolism (Academic Press), in press (1975).Google Scholar
  44. [44]
    L.T. Skeggs, J.R. Kahn andN.P. Shumway,Preparation and Function of the Hypertensin-Converting Enzyme, J. exp. Med.103, 295–299 (1956).CrossRefPubMedGoogle Scholar
  45. [45]
    T. Nakajima, G. Oshima, H.S.J. Yeh, R. Igic andE.G. Erdös,Purification of the Angiotensin I Converting Enzyme of the Lung, Biochim. biophys. Acta315, 430–438 (1973).Google Scholar
  46. [46]
    D.W. Cushman andH.S. Cheung,Concentrations of Angiotensin-Converting Enzyme in Tissues of the Rat, Biochim. biophys. Acta250, 261–265 (1971).PubMedGoogle Scholar
  47. [47]
    C.G. Huggins, R.J. Corcoran, J.S. Gordon, H.W. Henry andJ.P. John,Kinetics of the Plasma and Lung Angiotensin I Converting Enzymes, Circ. Res.26/27, suppl. I I-93–I-108 (1970).Google Scholar
  48. [48]
    B.L. Fanburg andJ.B. Glazier,Conversion of Angiotensin I to Angiotensin II in the Isolated Perfused Dog Lung, J. appl. Physiol.35, 325–331 (1973).PubMedGoogle Scholar
  49. [49]
    U. Smith andJ.W. Ryan,Electron Microscopy of Endothelial and Epithelial Components of the Lungs: Correlations of Structure and Function, Fed. Proc.32, 1957–1966 (1973).PubMedGoogle Scholar
  50. [50]
    J.W. Ryan andU.S. Ryan,Biochemical and Morphological Aspects of the Actions and Metabolism of Kinins, in:J.J. Pisano andK.F. Austen, Fogarty Inter. Center Proc., No. 27 (US Government Printing Office, Washington, D.C.), in press (1975).Google Scholar

Copyright information

© Birkhäuser-Verlag 1976

Authors and Affiliations

  • J. W. Ryan
    • 1
  • Una S. Ryan
    • 1
  1. 1.Papanicolaou Cancer Research InstituteMiami

Personalised recommendations